Vimseltinib
Vimseltinib (DCC-3014) is a potent small molecule inhibitor targeting c-FMS (CSF-1R) and c-Kit with IC50 values of <0.01 μM and 0.1-1 μM, respectively. It is utilized in research exploring tumor-associated macrophages and has demonstrated activity in both in vitro cellular assays and in vivo models of tenosynovial giant cell tumor.
Product Specifications
CAS Number
1628606-05-2
Product Name Alternative
Inhibit, DCC 3014, DCC3014, DCC-3014, Inhibitor, colony stimulating factor 1 receptor, CD117, cFms, c-Fms, c-FMS/CSF-IR, c-Kit, cKit, CSF-1 receptor, CSF1R, CSF-1R, Vimseltinib, SCFR
Field of Research
Signal Transduction
Purity
98.98% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.65 mM) ; DMSO:60 mg/mL (139.05 mM)
Smiles
CC (C) Nc1ncc (-c2ccc (Oc3ccnc (c3) -c3cnn (C) c3) c (C) n2) c (=O) n1C
Molecular Formula
C23H25N7O2
Molecular Weight
431.49
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7096420 Inquire
Recombinant Nostoc sp. Cobalamin synthase (cobS), partial
Sign In for Pricing
View Details 